bayer cropscience limited
bayer cropscience limited Company Information
Company Number
00218826
Website
cropscience.bayer.co.ukRegistered Address
230 cambridge science park, milton road, cambridge, CB4 0WB
Industry
Wholesale of chemical products
Telephone
08081969522
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
bayer plc 100%
bayer cropscience limited Estimated Valuation
Pomanda estimates the enterprise value of BAYER CROPSCIENCE LIMITED at £148.9m based on a Turnover of £238.6m and 0.62x industry multiple (adjusted for size and gross margin).
bayer cropscience limited Estimated Valuation
Pomanda estimates the enterprise value of BAYER CROPSCIENCE LIMITED at £61m based on an EBITDA of £8.6m and a 7.1x industry multiple (adjusted for size and gross margin).
bayer cropscience limited Estimated Valuation
Pomanda estimates the enterprise value of BAYER CROPSCIENCE LIMITED at £211.8m based on Net Assets of £100.6m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bayer Cropscience Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Bayer Cropscience Limited Overview
Bayer Cropscience Limited is a live company located in cambridge, CB4 0WB with a Companies House number of 00218826. It operates in the wholesale of chemical products sector, SIC Code 46750. Founded in January 1927, it's largest shareholder is bayer plc with a 100% stake. Bayer Cropscience Limited is a mature, mega sized company, Pomanda has estimated its turnover at £238.6m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bayer Cropscience Limited Health Check
Pomanda's financial health check has awarded Bayer Cropscience Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
5 Strong
3 Regular
4 Weak
Size
annual sales of £238.6m, make it larger than the average company (£21m)
£238.6m - Bayer Cropscience Limited
£21m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a similar rate (4.4%)
5% - Bayer Cropscience Limited
4.4% - Industry AVG
Production
with a gross margin of 13.4%, this company has a higher cost of product (19.4%)
13.4% - Bayer Cropscience Limited
19.4% - Industry AVG
Profitability
an operating margin of 2.8% make it less profitable than the average company (6.4%)
2.8% - Bayer Cropscience Limited
6.4% - Industry AVG
Employees
with 113 employees, this is above the industry average (18)
113 - Bayer Cropscience Limited
18 - Industry AVG
Pay Structure
on an average salary of £108.6k, the company has a higher pay structure (£63.4k)
£108.6k - Bayer Cropscience Limited
£63.4k - Industry AVG
Efficiency
resulting in sales per employee of £2.1m, this is more efficient (£956.6k)
£2.1m - Bayer Cropscience Limited
£956.6k - Industry AVG
Debtor Days
it gets paid by customers after 14 days, this is earlier than average (57 days)
14 days - Bayer Cropscience Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 7 days, this is quicker than average (33 days)
7 days - Bayer Cropscience Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 55 days, this is in line with average (53 days)
55 days - Bayer Cropscience Limited
53 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 11 weeks, this is average cash available to meet short term requirements (11 weeks)
11 weeks - Bayer Cropscience Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 36.4%, this is a lower level of debt than the average (49.7%)
36.4% - Bayer Cropscience Limited
49.7% - Industry AVG
bayer cropscience limited Credit Report and Business Information
Bayer Cropscience Limited Competitor Analysis
Perform a competitor analysis for bayer cropscience limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
bayer cropscience limited Ownership
BAYER CROPSCIENCE LIMITED group structure
Bayer Cropscience Limited has 2 subsidiary companies.
Ultimate parent company
BAYER AG
#0000526
2 parents
BAYER CROPSCIENCE LIMITED
00218826
2 subsidiaries
bayer cropscience limited directors
Bayer Cropscience Limited currently has 4 directors. The longest serving directors include Mr Vinit Jindal (Aug 2021) and Dr Ramon Payano Baez (Sep 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Vinit Jindal | England | 50 years | Aug 2021 | - | Director |
| Dr Ramon Payano Baez | England | 52 years | Sep 2021 | - | Director |
| Mr Nils Bauer | England | 42 years | Mar 2022 | - | Director |
| Mr Nils Bauer | England | 42 years | Mar 2022 | - | Director |
BAYER CROPSCIENCE LIMITED financials
Bayer Cropscience Limited's latest turnover from December 2022 is £238.6 million and the company has net assets of £100.6 million. According to their latest financial statements, Bayer Cropscience Limited has 113 employees and maintains cash reserves of £6.7 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 238,648,000 | 215,327,000 | 195,646,000 | 207,538,000 | 246,291,000 | 270,982,000 | 283,613,000 | 297,748,000 | 331,482,000 | 315,066,000 | 307,613,000 | 278,244,000 | 256,062,000 | 260,711,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 206,793,000 | 178,839,000 | 167,142,000 | 178,808,000 | 211,407,000 | 227,964,000 | 243,241,000 | 254,138,000 | 270,198,000 | 257,785,000 | 246,320,000 | 216,455,000 | 193,516,000 | 192,243,000 |
| Gross Profit | 31,855,000 | 36,488,000 | 28,504,000 | 28,730,000 | 34,884,000 | 43,018,000 | 40,372,000 | 43,610,000 | 61,284,000 | 57,281,000 | 61,293,000 | 61,789,000 | 62,546,000 | 68,468,000 |
| Admin Expenses | 25,069,000 | 19,691,000 | 19,507,000 | 20,523,000 | 20,621,000 | 22,785,000 | 31,304,000 | 30,940,000 | 34,493,000 | 39,351,000 | 38,751,000 | 33,958,000 | 41,357,000 | 53,086,000 |
| Operating Profit | 6,786,000 | 16,797,000 | 8,997,000 | 8,207,000 | 14,263,000 | 20,233,000 | 9,068,000 | 12,670,000 | 26,791,000 | 17,930,000 | 22,542,000 | 27,831,000 | 21,189,000 | 15,382,000 |
| Interest Payable | 414,000 | 181,000 | 175,000 | 1,281,000 | 1,870,000 | 3,757,000 | 2,587,000 | 53,000 | 56,000 | 926,000 | 523,000 | 1,554,000 | 2,664,000 | 30,692,000 |
| Interest Receivable | 2,278,000 | 391,000 | 475,000 | 10,275,000 | 317,000 | 138,000 | 106,000 | 165,000 | 142,000 | 54,000 | 153,000 | 63,000 | 57,000 | 26,789,000 |
| Pre-Tax Profit | 8,926,000 | 14,240,000 | 3,928,000 | 3,768,000 | 12,516,000 | 16,614,000 | 6,587,000 | 9,782,000 | 23,877,000 | 16,158,000 | 6,989,000 | -4,608,000 | 18,582,000 | 9,494,000 |
| Tax | -1,755,000 | -2,952,000 | -1,731,000 | -1,351,000 | -1,778,000 | -3,129,000 | -1,122,000 | -2,230,000 | -4,648,000 | -4,833,000 | -2,681,000 | 745,000 | -5,439,000 | -3,295,000 |
| Profit After Tax | 7,171,000 | 11,288,000 | 2,197,000 | 2,417,000 | 10,738,000 | 13,485,000 | 5,465,000 | 7,552,000 | 19,229,000 | 11,325,000 | 4,308,000 | -3,863,000 | 13,143,000 | 6,199,000 |
| Dividends Paid | 0 | 0 | 10,000,000 | 30,000,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 7,171,000 | 11,288,000 | -7,803,000 | -27,583,000 | 10,738,000 | 13,485,000 | 5,465,000 | 7,552,000 | 19,229,000 | 11,325,000 | 4,308,000 | -3,863,000 | 13,143,000 | 6,199,000 |
| Employee Costs | 12,272,000 | 11,855,000 | 11,889,000 | 11,865,000 | 11,289,000 | 11,044,000 | 16,244,000 | 13,045,000 | 12,771,000 | 13,104,000 | 24,029,000 | 26,561,000 | 23,113,000 | 28,750,000 |
| Number Of Employees | 113 | 111 | 118 | 122 | 123 | 134 | 157 | 160 | 154 | 155 | 324 | 417 | 447 | 501 |
| EBITDA* | 8,589,000 | 18,902,000 | 11,107,000 | 9,788,000 | 14,878,000 | 20,929,000 | 9,068,000 | 13,586,000 | 28,679,000 | 20,759,000 | 26,194,000 | 37,270,000 | 30,017,000 | 22,883,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 4,533,000 | 148,448,000 | 47,672,000 | 54,209,000 | 50,475,000 | 18,989,000 | 30,339,000 | 1,548,000 | 1,622,000 | 1,581,000 | 1,537,000 | 1,883,000 | 46,449,000 | 41,717,000 |
| Intangible Assets | 513,000 | 544,000 | 355,000 | 413,000 | 0 | 0 | 251,000 | 636,000 | 697,000 | 1,577,000 | 3,958,000 | 6,930,000 | 10,619,000 | 13,887,000 |
| Investments & Other | 63,946,000 | 0 | 17,267,000 | 22,636,000 | 36,069,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15,440,000 | 15,440,000 |
| Debtors (Due After 1 year) | 0 | 139,800,000 | 24,739,000 | 13,225,000 | 9,253,000 | 17,467,000 | 28,758,000 | 18,042,000 | 22,500,000 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 68,992,000 | 148,992,000 | 48,027,000 | 41,397,000 | 50,475,000 | 18,989,000 | 30,590,000 | 20,226,000 | 24,819,000 | 3,158,000 | 5,495,000 | 8,813,000 | 72,508,000 | 71,044,000 |
| Stock & work in progress | 31,444,000 | 47,885,000 | 52,842,000 | 33,362,000 | 29,285,000 | 25,435,000 | 23,993,000 | 36,496,000 | 32,703,000 | 44,686,000 | 45,844,000 | 41,775,000 | 36,732,000 | 41,624,000 |
| Trade Debtors | 9,528,000 | 13,135,000 | 6,887,000 | 9,180,000 | 19,774,000 | 13,520,000 | 16,813,000 | 13,870,000 | 16,632,000 | 22,795,000 | 13,558,000 | 19,463,000 | 17,936,000 | 22,766,000 |
| Group Debtors | 29,974,000 | 31,433,000 | 7,344,000 | 36,810,000 | 63,125,000 | 96,826,000 | 87,911,000 | 81,188,000 | 97,508,000 | 66,298,000 | 94,588,000 | 85,599,000 | 69,037,000 | 62,914,000 |
| Misc Debtors | 11,464,000 | 6,307,000 | 6,497,000 | 2,048,000 | 564,000 | 580,000 | 3,779,000 | 3,976,000 | 1,489,000 | 7,538,000 | 13,129,000 | 11,697,000 | 7,967,000 | 4,035,000 |
| Cash | 6,697,000 | 3,302,000 | 5,741,000 | 0 | 0 | 0 | 57,000 | 139,000 | 171,000 | 245,000 | 74,000 | 2,456,000 | 774,000 | 2,430,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 89,107,000 | 102,062,000 | 79,311,000 | 82,177,000 | 112,748,000 | 136,361,000 | 132,553,000 | 135,669,000 | 148,503,000 | 141,562,000 | 167,193,000 | 160,990,000 | 132,446,000 | 133,769,000 |
| total assets | 158,099,000 | 251,054,000 | 127,338,000 | 123,574,000 | 163,223,000 | 155,350,000 | 163,143,000 | 155,895,000 | 173,322,000 | 144,720,000 | 172,688,000 | 169,803,000 | 204,954,000 | 204,813,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 4,405,000 | 20,254,000 | 13,725,000 | 10,009,000 | 10,387,000 | 11,010,000 | 9,471,000 | 12,132,000 | 11,515,000 | 12,121,000 | 13,400,000 | 14,687,000 | 12,476,000 | 10,293,000 |
| Group/Directors Accounts | 15,521,000 | 0 | 0 | 0 | 0 | 0 | 0 | 1,699,000 | 1,170,000 | 1,774,000 | 39,748,000 | 20,125,000 | 73,019,000 | 48,819,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 1,106,000 | 820,000 | 761,000 | 796,000 | 883,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 8,995,000 | 10,352,000 | 17,270,000 | 9,716,000 | 15,760,000 | 16,478,000 | 19,485,000 | 11,087,000 | 19,581,000 | 13,462,000 | 13,210,000 | 15,933,000 | 14,497,000 | 16,477,000 |
| total current liabilities | 30,027,000 | 31,426,000 | 31,756,000 | 20,521,000 | 27,030,000 | 27,488,000 | 28,956,000 | 24,918,000 | 32,266,000 | 27,357,000 | 66,358,000 | 50,745,000 | 99,992,000 | 75,589,000 |
| loans | 0 | 4,008,000 | 4,610,000 | 5,762,000 | 6,988,000 | 0 | 0 | 0 | 0 | 0 | 1,253,000 | 2,470,000 | 6,049,000 | 8,135,000 |
| hp & lease commitments | 1,732,000 | 2,004,000 | 2,305,000 | 2,881,000 | 3,494,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 25,764,000 | 81,584,000 | 16,876,000 | 15,304,000 | 101,684,000 | 176,552,000 | 300,252,000 | 79,239,000 | 93,422,000 | 1,706,000 | 2,244,000 | 5,000,000 | 5,901,000 | 19,393,000 |
| total long term liabilities | 27,496,000 | 42,796,000 | 10,743,000 | 10,533,000 | 54,336,000 | 88,276,000 | 150,126,000 | 79,239,000 | 93,422,000 | 61,546,000 | 91,739,000 | 64,995,000 | 61,517,000 | 100,320,000 |
| total liabilities | 57,523,000 | 74,222,000 | 42,499,000 | 31,054,000 | 81,366,000 | 115,764,000 | 179,082,000 | 104,157,000 | 125,688,000 | 88,903,000 | 158,097,000 | 115,740,000 | 161,509,000 | 175,909,000 |
| net assets | 100,576,000 | 176,832,000 | 84,839,000 | 92,520,000 | 81,857,000 | 39,586,000 | -15,939,000 | 51,738,000 | 47,634,000 | 55,817,000 | 14,591,000 | 54,063,000 | 43,445,000 | 28,904,000 |
| total shareholders funds | 100,576,000 | 176,832,000 | 84,839,000 | 92,520,000 | 81,857,000 | 39,586,000 | -15,939,000 | 51,738,000 | 47,634,000 | 55,817,000 | 14,591,000 | 54,063,000 | 43,445,000 | 28,904,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 6,786,000 | 16,797,000 | 8,997,000 | 8,207,000 | 14,263,000 | 20,233,000 | 9,068,000 | 12,670,000 | 26,791,000 | 17,930,000 | 22,542,000 | 27,831,000 | 21,189,000 | 15,382,000 |
| Depreciation | 1,630,000 | 1,999,000 | 1,995,000 | 1,575,000 | 389,000 | 388,000 | 466,000 | 453,000 | 448,000 | 680,000 | 6,126,000 | 5,458,000 | 5,511,000 | |
| Amortisation | 173,000 | 106,000 | 115,000 | 6,000 | 226,000 | 308,000 | 450,000 | 1,435,000 | 2,381,000 | 2,972,000 | 3,313,000 | 3,370,000 | 1,990,000 | |
| Tax | -1,755,000 | -2,952,000 | -1,731,000 | -1,351,000 | -1,778,000 | -3,129,000 | -1,122,000 | -2,230,000 | -4,648,000 | -4,833,000 | -2,681,000 | 745,000 | -5,439,000 | -3,295,000 |
| Stock | -16,441,000 | -4,957,000 | 19,480,000 | 4,077,000 | 3,850,000 | 1,442,000 | -12,503,000 | 3,793,000 | -11,983,000 | -1,158,000 | 4,069,000 | 5,043,000 | -4,892,000 | 41,624,000 |
| Debtors | -139,709,000 | 145,208,000 | -15,796,000 | -31,453,000 | -35,677,000 | -8,868,000 | 20,185,000 | -21,053,000 | 41,498,000 | -24,644,000 | 4,516,000 | 21,819,000 | 5,225,000 | 89,715,000 |
| Creditors | -15,849,000 | 6,529,000 | 3,716,000 | -378,000 | -623,000 | 1,539,000 | -2,661,000 | 617,000 | -606,000 | -1,279,000 | -1,287,000 | 2,211,000 | 2,183,000 | 10,293,000 |
| Accruals and Deferred Income | -1,357,000 | -6,918,000 | 7,554,000 | -6,044,000 | -718,000 | -3,007,000 | 8,398,000 | -8,494,000 | 6,119,000 | 252,000 | -2,723,000 | 1,436,000 | -1,980,000 | 16,477,000 |
| Deferred Taxes & Provisions | -55,820,000 | 64,708,000 | 1,572,000 | -86,380,000 | -74,868,000 | -123,700,000 | 221,013,000 | -14,183,000 | 91,716,000 | -538,000 | -2,756,000 | -901,000 | -13,492,000 | 19,393,000 |
| Cash flow from operations | 89,958,000 | -59,982,000 | 18,534,000 | -56,989,000 | -31,282,000 | -99,942,000 | 6,556,000 | 91,745,000 | 40,163,000 | 8,162,000 | 13,899,000 | 10,956,000 | -65,588,000 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 63,946,000 | -17,267,000 | -5,369,000 | -13,433,000 | 36,069,000 | 0 | 0 | 0 | 0 | 0 | 0 | -15,440,000 | 0 | 15,440,000 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 15,521,000 | 0 | 0 | 0 | 0 | 0 | -1,699,000 | 529,000 | -604,000 | -37,974,000 | 19,623,000 | -52,894,000 | 24,200,000 | 48,819,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -4,008,000 | -602,000 | -1,152,000 | -1,226,000 | 6,988,000 | 0 | 0 | 0 | 0 | -1,253,000 | -1,217,000 | -3,579,000 | -2,086,000 | 8,135,000 |
| Hire Purchase and Lease Commitments | 14,000 | -242,000 | -611,000 | -700,000 | 4,377,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 1,864,000 | 210,000 | 300,000 | 8,994,000 | -1,553,000 | -3,619,000 | -2,481,000 | 112,000 | 86,000 | -872,000 | -370,000 | -1,491,000 | -2,607,000 | -3,903,000 |
| cash flow from financing | -70,036,000 | 80,071,000 | -1,341,000 | 45,314,000 | 41,345,000 | 38,421,000 | -77,322,000 | -2,807,000 | -27,930,000 | -10,198,000 | -25,744,000 | -43,483,000 | 20,905,000 | 75,756,000 |
| cash and cash equivalents | ||||||||||||||
| cash | 3,395,000 | -2,439,000 | 5,741,000 | 0 | 0 | -57,000 | -82,000 | -32,000 | -74,000 | 171,000 | -2,382,000 | 1,682,000 | -1,656,000 | 2,430,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 3,395,000 | -2,439,000 | 5,741,000 | 0 | 0 | -57,000 | -82,000 | -32,000 | -74,000 | 171,000 | -2,382,000 | 1,682,000 | -1,656,000 | 2,430,000 |
P&L
December 2022turnover
238.6m
+11%
operating profit
6.8m
-60%
gross margin
13.4%
-21.23%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
100.6m
-0.43%
total assets
158.1m
-0.37%
cash
6.7m
+1.03%
net assets
Total assets minus all liabilities
Similar Companies
bayer cropscience limited company details
company number
00218826
Type
Private limited with Share Capital
industry
46750 - Wholesale of chemical products
incorporation date
January 1927
age
97
accounts
Full Accounts
ultimate parent company
previous names
aventis cropscience uk limited (September 2002)
agrevo uk limited (January 2000)
See moreincorporated
UK
address
230 cambridge science park, milton road, cambridge, CB4 0WB
last accounts submitted
December 2022
bayer cropscience limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bayer cropscience limited.
bayer cropscience limited Companies House Filings - See Documents
| date | description | view/download |
|---|
